Photon-counting computed tomography (PCCT) is a new type of CT scanner that uses a fundamentally different detector technology from conventional CT. While conventional CT scanners have used energy-integrating detectors (EIDs) for decades, PCCT uses photon-counting detectors (PCDs) that directly convert X-ray photons into electrical signals and measure the energy of each individual photon.
The U.S. Food and Drug Administration (FDA) cleared the first PCCT system — the Siemens Naeotom Alpha — in 2021. Since then, additional systems have received FDA 510(k) clearance, including the Siemens Naeotom Alpha class (February 2025) and the GE HealthCare Photonova Spectra (March 2026). PCCT is now clinically available, though it remains an evolving technology rather than routine practice.
Understanding PCCT requires a quick review of how conventional CT detectors work.
In a conventional CT scanner, the detector uses a two-step process:
This approach has limitations:
PCCT replaces the scintillator-photodiode combination with a semiconductor detector (typically cadmium telluride or silicon). The process is direct:
This direct approach offers several advantages:
As of September 2026, multiple PCCT systems have received FDA 510(k) clearance:
| System | Manufacturer | FDA Clearance | Key Feature |
|---|---|---|---|
| Naeotom Alpha | Siemens Healthineers | 2021 | World's first PCCT; dual-source |
| Naeotom Alpha.Peak / Pro / Prime | Siemens Healthineers | February 2025 | Single-source options; Alpha.Prime scan speed 345 mm/sec |
| Photonova Spectra | GE HealthCare | March 2026 | Deep Silicon detector technology |
These systems are installed at academic medical centers and large hospitals. However, PCCT is not yet widespread — cost and workflow integration remain barriers to broader adoption.
If you work at a facility that installs a PCCT system, several practical differences may affect your workflow:
PCCT systems can acquire spectral data from every scan, but this does not mean every scan should use spectral reconstruction. Protocols must still be optimized for the clinical question. The availability of spectral data does not replace the need for appropriate kVp selection and dose management.
PCCT generates more data per scan than conventional CT. Depending on the system and protocol, radiographers may need to select from additional reconstruction options, including virtual monoenergetic images, material decomposition maps, and iodine quantification. Familiarity with these options will be important.
The American Association of Physicists in Medicine (AAPM) Task Group 299 has published guidance on quality control for multi-energy CT systems. PCCT requires QC procedures specific to photon-counting detectors, which differ from conventional EID QC. Medical physicists will establish these protocols, but radiographers should understand that PCCT QC is not identical to conventional CT QC.
PCCT represents a significant technology transition. Facilities adopting PCCT typically provide vendor-specific training for radiologists, radiographers, and medical physicists. The learning curve is real — this is not simply a software upgrade to existing scanners.
The clinical evidence for PCCT is accumulating but still evolving.
According to a 2026 review in the European Journal of Radiology, PCCT merges "superior spatial resolution, spectral separation, and dose efficiency into a single technology." The International Society for Computed Tomography (ISCT) notes expanding applications across cardiovascular, neuro, musculoskeletal, and oncologic imaging, with particular promise for:
A 2026 American Journal of Roentgenology counterpoint article cautions that evidence remains insufficient for some applications, workflow challenges exist, and economic barriers are significant. The transition from technical validation to routine clinical integration is ongoing.
The ISCT similarly notes that "attention is shifting from technical validation to workflow integration and clinical implementation," with protocol optimization, data management, and spectral interpretation identified as active areas of development.
PCCT is clinically available and expanding, but it is not yet routine. It offers real advantages in resolution and spectral capability, but workflow integration and cost remain active challenges. Staying informed about this technology — without overestimating its current adoption — is the appropriate professional stance.
| Feature | Conventional EID CT | Photon-Counting CT |
|---|---|---|
| Detector type | Scintillator + photodiode | Semiconductor (CdTe or silicon) |
| Signal process | Integration over time | Individual photon counting |
| Energy information | Lost | Measured and binned |
| Electronic noise | Present | Eliminated |
| Spatial resolution | Standard | Higher (smaller detector elements) |
| Spectral imaging | Requires dual-source or rapid kVp switching | Intrinsic to every scan |
| Clinical availability | Routine worldwide | Limited but expanding |
| FDA clearance | Multiple systems since 1970s | First clearance 2021 |
PCCT represents a meaningful step forward in CT technology. The FDA clearance of multiple systems from different manufacturers indicates that this is not a single-vendor experiment but a genuine technology transition.
For radiography students, understanding PCCT principles will become increasingly important as these systems enter clinical practice. For working radiographers, PCCT may represent a future skill requirement, particularly at academic centers and large hospitals.
The key takeaway: PCCT is clinically available and expanding, but it is not yet routine. It offers real advantages in resolution and spectral capability, but workflow integration and cost remain active challenges.
Want to learn more about CT? Read CT Scan Physics: HU, Windowing & Helical CT or explore our CT Scan modality overview.